Blake D A, Farquhar C M, Johnson N, Proctor M
Auckland University of Technology, Biotechnology Research Institute, Private Bag 92006, Auckland, New Zealand, 1020.
Cochrane Database Syst Rev. 2007 Oct 17(4):CD002118. doi: 10.1002/14651858.CD002118.pub3.
Recent advances in cell culture media have led to a shift in IVF practice from early cleavage embryo transfer to blastocyst stage transfer. The rationale for blastocyst culture is to improve both uterine and embryonic synchronicity and self selection of viable embryos thus resulting in higher implantation rates.
To determine if blastocyst stage embryo transfers (ETs) affect live birth rate and associated outcomes compared with cleavage stage ETs and to investigate what factors may influence this.
Cochrane Menstrual Disorders and Subfertility Group Specialised Register of controlled trials, Cochrane Controlled Trials Register (CENTRAL) (The Cochrane Library), MEDLINE, EMBASE and Bio extracts. The last search date was January 2007.
Trials were included if they were randomised and compared the effectiveness of early cleavage versus blastocyst stage transfers.
Of the 50 trials that were identified, 18 randomised controlled trials (RCTs) met the inclusion criteria and were reviewed. The primary outcome was rate of live birth. Secondary outcomes were rates per couple of clinical pregnancy, multiple pregnancy, high order pregnancy, miscarriage, failure to transfer embryos and cryopreservation. Quality assessment, data extraction and meta-analysis were performed following Cochrane guidelines.
Evidence of a significant difference in live-birth rate per couple between the two treatment groups was detected in favour of blastocyst culture (9 RCTs; OR 1.35, 95% CI 1.05 to 1.74 (Day 2/3: 29.4% versus Day 5/6: 36.0%)). This was particularly for trials with good prognosis patients, equal number of embryos transferred (including single embryo transfer) and those in which the randomisation took place on Day 3. Rates of embryo freezing per couple was significantly higher in Day 2 to 3 transfers (9 RCTs; OR 0.45, 95% CI 0.36 to 0.56). Failure to transfer any embryos per couple was significantly higher in the Day 5 to 6 group (16 RCTs; OR 2.85, 95% CI 1.97 to 4.11 (Day 2/3: 2.8% versus Day 5/6: 8.9%)) but was not significantly different for good prognosis patients (9 RCTs; OR 1.50, 95% CI 0.79 to 2.84).
AUTHORS' CONCLUSIONS: This review provides evidence that there is a significant difference in pregnancy and live birth rates in favour of blastocyst transfer with good prognosis patients with high numbers of eight-cell embryos on Day three being the most favoured in subgroup for whom there is no difference in cycle cancellation. There is emerging evidence to suggest that in selected patients, blastocyst culture maybe applicable for single embryo transfer.
细胞培养基的最新进展已使体外受精实践从早期卵裂胚胎移植转向囊胚期移植。囊胚培养的基本原理是提高子宫与胚胎的同步性以及存活胚胎的自我选择能力,从而提高着床率。
确定与卵裂期胚胎移植相比,囊胚期胚胎移植(ET)是否会影响活产率及相关结局,并研究哪些因素可能对此产生影响。
考克兰月经紊乱与生育力低下小组专业对照试验注册库、考克兰对照试验注册库(CENTRAL)(考克兰图书馆)、医学索引数据库、荷兰医学文摘数据库和生物提取物数据库。最后检索日期为2007年1月。
纳入的试验需为随机试验,并比较早期卵裂与囊胚期移植的有效性。
在识别出的50项试验中,18项随机对照试验(RCT)符合纳入标准并进行了综述。主要结局为活产率。次要结局为每对夫妇的临床妊娠率、多胎妊娠率、高序妊娠率、流产率、未移植胚胎率和冷冻保存率。按照考克兰指南进行质量评估、数据提取和荟萃分析。
检测到两组治疗组每对夫妇活产率存在显著差异,支持囊胚培养(9项RCT;比值比1.35,95%可信区间1.05至1.74(第2/3天:29.4%对第5/6天:36.0%))。这在预后良好的患者、移植胚胎数量相等(包括单胚胎移植)以及第3天进行随机分组的试验中尤为明显。第2至3天移植的每对夫妇胚胎冷冻率显著更高(9项RCT;比值比0.45,95%可信区间0.36至0.56)。第5至6天组每对夫妇未移植任何胚胎的比例显著更高(16项RCT;比值比2.85,95%可信区间1.97至4.11(第2/3天:2.8%对第5/6天:8.9%)),但预后良好的患者之间无显著差异(9项RCT;比值比1.50,95%可信区间0.79至2.84)。
本综述提供的证据表明,妊娠率和活产率存在显著差异,支持对预后良好且第3天有大量八细胞胚胎的患者进行囊胚移植,对于此类亚组患者,周期取消率无差异。新出现的证据表明,在特定患者中,囊胚培养可能适用于单胚胎移植。